In the light of the emerging role of the ICOS/ICOSL/OPN trio in cancer progression, inflammation, adaptive immunity, and bone metabolism, this trio might be targeted in various ways in order to influence these processes in several human diseases. Here, ICOSLG is linked to cancer.